Survival outcomes of adjuvant chemotherapy with modified weekly nab-paclitaxel and carboplatin for completely resected nonsmall cell lung cancer: FAST-nab

Marushima, H; Kimura, H; Miyazawa, T; Sakai, H; Furuya, N; Koji, K; Nakamura, H; Saji, H

Saji, H (corresponding author), St Marianna Univ, Sch Med, Dept Chest Surg, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.

ANTI-CANCER DRUGS, 2020; 31 (2): 177

Abstract

The relatively low toxicity profile of nab-paclitaxel plus carboplatin and its feasibility as an adjuvant administration was reported previously. This......

Full Text Link